Subscribe
The latest psychology and neuroscience discoveries.
My Account
  • Mental Health
  • Social Psychology
  • Cognitive Science
  • Psychopharmacology
  • Neuroscience
  • About
No Result
View All Result
PsyPost
PsyPost
No Result
View All Result
Home Exclusive Mental Health Depression

Individuals with high triglyceride-glucose index are more likely to suffer from depression

by Vladimir Hedrih
August 13, 2024
in Depression
(Photo credit: Adobe Stock)

(Photo credit: Adobe Stock)

Share on TwitterShare on Facebook
Stay informed on the latest psychology and neuroscience research—follow PsyPost on LinkedIn for daily updates and insights.

A new meta-analysis has reported that individuals with a high triglyceride-glucose index have a 41% greater likelihood of suffering from depression compared to those with lower values of this index. These results remained consistent across individuals both above and below 50 years of age, as well as across different genders. The research was published in Frontiers in Psychiatry.

Depression is a common mental health disorder characterized by persistent feelings of sadness, hopelessness, and a lack of interest or pleasure in activities. The severity of depression can vary, and it can be influenced by a variety of genetic, biological, environmental, and psychological factors. Factors associated with an increased risk of depression include genetic predisposition, chronic stress, trauma, and significant life changes such as loss or illness. Additionally, underlying medical conditions, substance abuse, and social isolation can also contribute to the likelihood of developing depression.

Recent studies have also linked an increased risk of depression to obesity and type 2 diabetes. The key underlying issue with type 2 diabetes is insulin resistance, a condition in which the body’s cells become less responsive to the hormone insulin, leading to impaired glucose uptake and elevated blood sugar levels. Recently, a novel indicator of insulin resistance, the triglyceride-glucose index, was developed. This index is calculated from serum triglyceride and fasting plasma glucose values.

Triglycerides are a type of fat present in the blood, while fasting plasma glucose values indicate the amount of glucose (a simple sugar that serves as the primary source of energy for the body’s cells) in the blood after a period of fasting. Both are important indicators of metabolic health.

Study authors Weitao Wan and Yi Yu sought to evaluate the association between the triglyceride-glucose index and depression in the adult population. They noted that results reported in previous studies were inconsistent, which motivated them to integrate these findings by conducting a meta-analysis.

The authors searched Medline, Web of Science, Embase, Wanfang, and China National Knowledge Internet databases using various terms related to the triglyceride-glucose index and depression. They focused on studies conducted on adults without specific diagnoses or somatic diseases that reported data on both depression and the triglyceride-glucose index.

The search yielded 67 potentially relevant texts. Upon closer inspection, six studies met all the necessary criteria and provided the required data for inclusion in the analysis. These six studies included eight datasets involving a total of 28,973 adults.

The number of participants per study ranged from 387 to 13,350, with 77% of participants coming from just the two largest studies. The proportion of participants with depression varied widely, ranging from 7% to over 50%. The mean age of study participants ranged from 44 to 59 years.

The results showed that individuals with high triglyceride-glucose index values had 41% higher odds of depression compared to those with lower values. The variability of these odds across studies was relatively small. The results were consistent among individuals both above and below 50 years of age and across different genders.

“Although large-scale prospective studies are needed to validate the results, the findings of this meta-analysis support the potential association between a high TyG [triglyceride glucose] index and the prevalence of depression in general population,” the study authors concluded.

The study highlights the potential links between depression and triglyceride-glucose index values. However, it is important to note that the proportion of individuals with depression in several of the studies included in the analysis was much higher than in the general population. While common estimates suggest that the lifetime prevalence of depression in the population is between 5% and 17%, three of the studies in this meta-analysis reported depression rates near or above 50%, while one study did not report this information.

The paper, “Association between the triglyceride glucose index and depression: a meta-analysis,” was authored by Weitao Wan and Yi Yu.

TweetSendScanShareSendPin1ShareShareShareShareShare

RELATED

Cognitive training may reduce negative self-perceptions in people with depression and PTSD
Depression

Cognitive training may reduce negative self-perceptions in people with depression and PTSD

May 21, 2025

Underestimating one’s own cognitive abilities is common in depression and PTSD. A new study finds that cognitive training—especially through engaging games—may help people recalibrate their self-perceptions and feel better.

Read moreDetails
Optimistic individuals are more likely to respond to SSRI antidepressants
Depression

Optimistic individuals are more likely to respond to SSRI antidepressants

May 19, 2025

People with depression who were more optimistic at the start of treatment—and whose optimism increased during treatment—were more likely to benefit from SSRIs, according to a recent study, raising the possibility of tailoring treatments based on psychological traits.

Read moreDetails
Inhaled DMT produces rapid and lasting antidepressant effects in treatment-resistant depression
Ayahuasca

Inhaled DMT produces rapid and lasting antidepressant effects in treatment-resistant depression

May 17, 2025

Vaporized DMT produced fast and lasting improvements in depression symptoms and suicidal ideation, according to a new phase 2a trial, highlighting its potential as a scalable, non-invasive alternative to conventional and long-acting psychedelic treatments for severe depression.

Read moreDetails
New research points to gut serotonin as a potential way to treat depression and anxiety
Depression

New research points to gut serotonin as a potential way to treat depression and anxiety

May 16, 2025

New research reveals that serotonin in the gut lining can reduce anxiety and depression symptoms in mice—without the side effects of traditional antidepressants—and may offer a safer alternative for treating mood disorders during pregnancy.

Read moreDetails
New research links postnatal depression to a disrupted oxytocin response during breastfeeding
Depression

New research links postnatal depression to a disrupted oxytocin response during breastfeeding

May 15, 2025

A new study finds that postnatal depression may impair the body’s hormonal response to breastfeeding. While oxytocin nasal spray boosted breast milk levels in healthy mothers, the same effect was not seen in those experiencing depressive symptoms after childbirth.

Read moreDetails
Stress-induced “fixated” eating patterns linked to dopamine disruption, study finds
Depression

New research links antidepressant effects of escitalopram to endocannabinoid system changes

May 12, 2025

In a rodent model of childhood adversity, escitalopram treatment during adolescence reduced signs of emotional distress. The study also found gene-level changes in the endocannabinoid system, pointing to a possible biological mechanism for the drug’s effectiveness.

Read moreDetails
Antidepressants may diminish psilocybin’s effects even after discontinuation
Depression

A single dose of psilocybin might help reduce symptoms in treatment-resistant depression

May 12, 2025

A new open-label study suggests that a single dose of psilocybin, combined with psychological support, may reduce symptoms in people with severe treatment-resistant depression. Improvements were sustained for up to 12 weeks, although effects were weaker in those with PTSD.

Read moreDetails
A pill bottle with pills inside
Depression

Common antidepressant may increase pain sensitivity later in life if taken during adolescence

May 11, 2025

A new animal study shows that adolescent use of fluoxetine, a commonly prescribed antidepressant, may have long-lasting effects on how the brain processes pain. Female mice exposed to the drug displayed increased sensitivity to heat stimuli as adults.

Read moreDetails

SUBSCRIBE

Go Ad-Free! Click here to subscribe to PsyPost and support independent science journalism!

STAY CONNECTED

LATEST

Gut bacteria can influence how brain proteins are modified by carbohydrates

“Tiger mom” parenting boosts teens’ cognitive skills but undermines emotional development, study suggests

Study uncovers three sexual power profiles—and only one is linked to relationship satisfaction

Neuroscientists discover how “aha” moments rewire the brain to enhance memory

Common blood pressure drug shows promise for treating ADHD symptoms

Cognitive training may reduce negative self-perceptions in people with depression and PTSD

Genetic essentialism more common among supporters of radical right-wing parties

Enjoying nature, not just visiting it, linked to greater happiness and life satisfaction, study finds

         
       
  • Contact us
  • Privacy policy
  • Terms and Conditions
[Do not sell my information]

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In

Add New Playlist

Subscribe
  • My Account
  • Cognitive Science Research
  • Mental Health Research
  • Social Psychology Research
  • Drug Research
  • Relationship Research
  • About PsyPost
  • Contact
  • Privacy Policy